{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:07Z","timestamp":1791396067221,"version":"4.3.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T00:00:00Z","timestamp":1333929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T00:00:00Z","timestamp":1333929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1038\/leu.2012.86","type":"journal-article","created":{"date-parts":[[2012,4,9]],"date-time":"2012-04-09T06:39:11Z","timestamp":1333953551000},"page":"2027-2031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies"],"prefix":"10.1038","volume":"26","author":[{"given":"F","family":"Damm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fontenay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O A","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,9]]},"reference":[{"key":"BFleu201286_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64\u201369.","journal-title":"Nature"},{"key":"BFleu201286_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ng.1031","volume":"44","author":"TA Graubert","year":"2011","unstructured":"Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, Shao J et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 2011; 44: 53\u201357.","journal-title":"Nat Genet"},{"key":"BFleu201286_CR3","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al. Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts. N Engl J Med 2011; 365: 1384\u20131395.","journal-title":"N Engl J Med"},{"key":"BFleu201286_CR4","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","volume":"365","author":"L Wang","year":"2011","unstructured":"Wang L, Lawrence MS, Wan Y, Stojanov P, Sougnez C, Stevenson K et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365: 2497\u20132506.","journal-title":"N Engl J Med"},{"key":"BFleu201286_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101\u2013105.","journal-title":"Nature"},{"key":"BFleu201286_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2011","unstructured":"Quesada V, Conde L, Villamor N, Ordonez GR, Jares P, Bassaganyas L et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2011; 44: 47\u201352.","journal-title":"Nat Genet"},{"key":"BFleu201286_CR7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389\u20131401.","journal-title":"J Exp Med"},{"key":"BFleu201286_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cell.2009.02.009","volume":"136","author":"MC Wahl","year":"2009","unstructured":"Wahl MC, Will CL, Luhrmann R . The spliceosome: design principles of a dynamic RNP machine. Cell 2009; 136: 701\u2013718.","journal-title":"Cell"},{"key":"BFleu201286_CR9","doi-asserted-by":"publisher","first-page":"4838","DOI":"10.1074\/jbc.273.9.4838","volume":"273","author":"M Hallier","year":"1998","unstructured":"Hallier M, Lerga A, Barnache S, Tavitian A, Moreau-Gachelin F . The transcription factor Spi-1\/PU.1 interacts with the potential splicing factor TLS. J Biol Chem 1998; 273: 4838\u20134842.","journal-title":"J Biol Chem"},{"key":"BFleu201286_CR10","doi-asserted-by":"publisher","first-page":"36935","DOI":"10.1074\/jbc.M501725200","volume":"280","author":"E Hiriart","year":"2005","unstructured":"Hiriart E, Gruffat H, Buisson M, Mikaelian I, Keppler S, Meresse P et al. Interaction of the Epstein-Barr virus mRNA export factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation and mRNA export. J Biol Chem 2005; 280: 36935\u201336945.","journal-title":"J Biol Chem"},{"key":"BFleu201286_CR11","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1073\/pnas.101001498","volume":"98","author":"T Mercher","year":"2001","unstructured":"Mercher T, Coniat MB, Monni R, Mauchauffe M, Nguyen Khac F, Gressin L et al. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci USA 2001; 98: 5776\u20135779.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201286_CR12","doi-asserted-by":"publisher","first-page":"36915","DOI":"10.1074\/jbc.M608745200","volume":"281","author":"S Lindtner","year":"2006","unstructured":"Lindtner S, Zolotukhin AS, Uranishi H, Bear J, Kulkarni V, Smulevitch S et al. RNA-binding motif protein 15 binds to the RNA transport element RTE and provides a direct link to the NXF1 export pathway. J Biol Chem 2006; 281: 36915\u201336928.","journal-title":"J Biol Chem"},{"key":"BFleu201286_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/90054","volume":"28","author":"Z Ma","year":"2001","unstructured":"Ma Z, Morris SW, Valentine V, Li M, Herbrick JA, Cui X et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet 2001; 28: 220\u2013221.","journal-title":"Nat Genet"},{"key":"BFleu201286_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.semcdb.2009.03.003","volume":"20","author":"S Xu","year":"2009","unstructured":"Xu S, Powers MA . Nuclear pore proteins and cancer. Semin Cell Dev Biol 2009; 20: 620\u2013630.","journal-title":"Semin Cell Dev Biol"},{"key":"BFleu201286_CR15","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","volume":"118","author":"SM Gough","year":"2011","unstructured":"Gough SM, Slape CI, Aplan PD . NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011; 118: 6247\u20136257.","journal-title":"Blood"},{"key":"BFleu201286_CR16","doi-asserted-by":"publisher","first-page":"10406","DOI":"10.1073\/pnas.1005389107","volume":"107","author":"Y Ren","year":"2010","unstructured":"Ren Y, Seo HS, Blobel G, Hoelz A . Structural and functional analysis of the interaction between the nucleoporin Nup98 and the mRNA export factor Rae1. Proc Natl Acad Sci USA 2010; 107: 10406\u201310411.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201286_CR17","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1128\/MCB.00342-06","volume":"26","author":"S Hutten","year":"2006","unstructured":"Hutten S, Kehlenbach RH . Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol Cell Biol 2006; 26: 6772\u20136785.","journal-title":"Mol Cell Biol"},{"key":"BFleu201286_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1101\/gad.1284605","volume":"19","author":"K Isono","year":"2005","unstructured":"Isono K, Mizutani-Koseki Y, Komori T, Schmidt-Zachmann MS, Koseki H . Mammalian polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1. Genes Dev 2005; 19: 536\u2013541.","journal-title":"Genes Dev"},{"key":"BFleu201286_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","volume":"20","author":"Y Kikushige","year":"2011","unstructured":"Kikushige Y, Ishikawa F, Miyamoto T, Shima T, Urata S, Yoshimoto G et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 2011; 20: 246\u2013259.","journal-title":"Cancer Cell"},{"key":"BFleu201286_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ccr.2011.06.003","volume":"20","author":"C Quivoron","year":"2011","unstructured":"Quivoron C, Couronne L, Della Valle V, Lopez CK, Plo I, Wagner-Ballon O et al. TET2 Inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011; 20: 25\u201338.","journal-title":"Cancer Cell"},{"key":"BFleu201286_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1056\/NEJMc1111708","volume":"366","author":"L Couronne","year":"2012","unstructured":"Couronne L, Bastard C, Bernard OA . TET2 and DNMT3A Mutations in Human T-Cell Lymphoma. N Engl J Med 2012; 366: 95\u201396.","journal-title":"N Engl J Med"},{"key":"BFleu201286_CR22","doi-asserted-by":"crossref","unstructured":"Damm F, Thol F, Kosmider O, Kade S, Loffeld P, Dreyfus F et al. SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia 2011; e-pub ahead of print 8 November 2011.","DOI":"10.1038\/leu.2011.321"},{"key":"BFleu201286_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1182\/blood-2011-09-377994","volume":"119","author":"MM Patnaik","year":"2011","unstructured":"Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G et al. SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. Blood 2011; 119: 569\u2013572.","journal-title":"Blood"},{"key":"BFleu201286_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/leu.2011.232","volume":"26","author":"V Visconte","year":"2011","unstructured":"Visconte V, Makishima H, Jankowska A, Szpurka H, Traina F, Jerez A et al. SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2011; 26: 542\u2013545.","journal-title":"Leukemia"},{"key":"BFleu201286_CR25","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","volume":"118","author":"L Malcovati","year":"2011","unstructured":"Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms. Blood 2011; 118: 6239\u20136246.","journal-title":"Blood"},{"key":"BFleu201286_CR26","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi D, Bruscaggin A, Spina V, Rasi S, Khiabanian H, Messina M et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118: 6904\u20136908.","journal-title":"Blood"},{"key":"BFleu201286_CR27","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","volume":"119","author":"H Makishima","year":"2012","unstructured":"Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012; 119: 3203\u20133210.","journal-title":"Blood"},{"key":"BFleu201286_CR28","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","volume":"119","author":"F Thol","year":"2012","unstructured":"Thol F, Kade S, Schlarmann C, Loffeld P, Morgan M, Krauter J et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012; 119: 3578\u20133584.","journal-title":"Blood"},{"key":"BFleu201286_CR29","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","volume":"119","author":"F Damm","year":"2012","unstructured":"Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C et al. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 2012; 119: 3211\u20133218.","journal-title":"Blood"},{"key":"BFleu201286_CR30","doi-asserted-by":"crossref","unstructured":"Zhang SJ, Rampal R, Manshouri T, Patel J, Mensah N, Kayserian A et al. Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms reveals recurrent SRSF2 mutations which are associated with adverse outcome. Blood 2012; e-pub ahead of print 19 March 2012.","DOI":"10.1182\/blood-2011-11-390252"},{"key":"BFleu201286_CR31","doi-asserted-by":"crossref","unstructured":"Will CL, Luhrmann R . Spliceosome structure and function. Cold Spring Harb Perspect Biol 2011; 3, pii: a003707.","DOI":"10.1101\/cshperspect.a003707"},{"key":"BFleu201286_CR32","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 230\u2013233.","journal-title":"Nature"},{"key":"BFleu201286_CR33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2011.08.023","volume":"147","author":"M Gabut","year":"2011","unstructured":"Gabut M, Samavarchi-Tehrani P, Wang X, Slobodeniuc V, O'Hanlon D, Sung HK et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011; 147: 132\u2013146.","journal-title":"Cell"},{"key":"BFleu201286_CR34","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.molcel.2010.11.005","volume":"40","author":"RD Alexander","year":"2010","unstructured":"Alexander RD, Innocente SA, Barrass JD, Beggs JD . Splicing-dependent RNA polymerase pausing in yeast. Mol Cell 2010; 40: 582\u2013593.","journal-title":"Mol Cell"},{"key":"BFleu201286_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.tcb.2011.03.002","volume":"21","author":"F Carrillo Oesterreich","year":"2011","unstructured":"Carrillo Oesterreich F, Bieberstein N, Neugebauer KM . Pause locally, splice globally. Trends Cell Biol 2011; 21: 328\u2013335.","journal-title":"Trends Cell Biol"},{"key":"BFleu201286_CR36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.gde.2011.03.004","volume":"21","author":"RF Luco","year":"2011","unstructured":"Luco RF, Misteli T. . More than a splicing code: integrating the role of RNA, chromatin and non-coding RNA in alternative splicing regulation. Curr Opin Genet Dev 2011; 21: 366\u2013372.","journal-title":"Curr Opin Genet Dev"},{"key":"BFleu201286_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1184208","volume":"327","author":"RF Luco","year":"2010","unstructured":"Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T . Regulation of alternative splicing by histone modifications. Science 2010; 327: 996\u20131000.","journal-title":"Science"},{"key":"BFleu201286_CR38","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1128\/MCB.21.20.6782-6795.2001","volume":"21","author":"E Martinez","year":"2001","unstructured":"Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, Kundu TK et al. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol 2001; 21: 6782\u20136795.","journal-title":"Mol Cell Biol"},{"key":"BFleu201286_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molcel.2011.06.035","volume":"44","author":"C Lemieux","year":"2011","unstructured":"Lemieux C, Marguerat S, Lafontaine J, Barbezier N, Bahler J, Bachand F . A Pre-mRNA degradation pathway that selectively targets intron-containing genes requires the nuclear poly(A)-binding protein. Mol Cell 2011; 44: 108\u2013119.","journal-title":"Mol Cell"},{"key":"BFleu201286_CR40","doi-asserted-by":"publisher","first-page":"8183","DOI":"10.1128\/MCB.14.12.8183","volume":"14","author":"A Jenny","year":"1994","unstructured":"Jenny A, Hauri HP, Keller W . Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit. Mol Cell Biol 1994; 14: 8183\u20138190.","journal-title":"Mol Cell Biol"},{"key":"BFleu201286_CR41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature09862","volume":"472","author":"B Montpetit","year":"2011","unstructured":"Montpetit B, Thomsen ND, Helmke KJ, Seeliger MA, Berger JM, Weis K . A conserved mechanism of DEAD-box ATPase activation by nucleoporins and InsP6 in mRNA export. Nature 2011; 472: 238\u2013242.","journal-title":"Nature"},{"key":"BFleu201286_CR42","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2174\/092986707782023677","volume":"14","author":"A Rosner","year":"2007","unstructured":"Rosner A, Rinkevich B . The DDX3 subfamily of the DEAD box helicases: divergent roles as unveiled by studying different organisms and in vitro assays. Curr Med Chem 2007; 14: 2517\u20132525.","journal-title":"Curr Med Chem"},{"key":"BFleu201286_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tcb.2007.02.003","volume":"17","author":"S Hutten","year":"2007","unstructured":"Hutten S, Kehlenbach RH . CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol 2007; 17: 193\u2013201.","journal-title":"Trends Cell Biol"},{"key":"BFleu201286_CR44","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471: 467\u2013472.","journal-title":"Nature"},{"key":"BFleu201286_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nsmb.1528","volume":"16","author":"D Schaeffer","year":"2009","unstructured":"Schaeffer D, Tsanova B, Barbas A, Reis FP, Dastidar EG, Sanchez-Rotunno M et al. The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities. Nat Struct Mol Biol 2009; 16: 56\u201362.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu201286_CR46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/nature10118","volume":"475","author":"EL van Dijk","year":"2011","unstructured":"van Dijk EL, Chen CL, d'Aubenton-Carafa Y, Gourvennec S, Kwapisz M, Roche V et al. XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast. Nature 2011; 475: 114\u2013117.","journal-title":"Nature"},{"key":"BFleu201286_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 2012; 481: 506\u2013510.","journal-title":"Nature"},{"key":"BFleu201286_CR48","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/01677063.2011.627072","volume":"25","author":"RE Drolet","year":"2011","unstructured":"Drolet RE, Sanders JM, Kern JT . Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions. J Neurogenet 2011; 25: 140\u2013151.","journal-title":"J Neurogenet"},{"key":"BFleu201286_CR49","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1053\/j.seminoncol.2011.04.010","volume":"38","author":"BL Ebert","year":"2011","unstructured":"Ebert BL . Molecular dissection of the 5q deletion in myelodysplastic syndrome. Semin Oncol 2011; 38: 621\u2013626.","journal-title":"Semin Oncol"},{"key":"BFleu201286_CR50","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1111\/j.1742-4658.2011.08387.x","volume":"278","author":"A Yokoi","year":"2011","unstructured":"Yokoi A, Kotake Y, Takahashi K, Kadowaki T, Matsumoto Y, Minoshima Y et al. Biological validation that SF3b is a target of the antitumor macrolide pladienolide. FEBS J 2011; 278: 4870\u20134880.","journal-title":"FEBS J"},{"key":"BFleu201286_CR51","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43: 830\u2013837.","journal-title":"Nat Genet"},{"key":"BFleu201286_CR52","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298\u2013303.","journal-title":"Nature"},{"key":"BFleu201286_CR53","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010; 42: 181\u2013185.","journal-title":"Nat Genet"},{"key":"BFleu201286_CR54","doi-asserted-by":"publisher","first-page":"20980","DOI":"10.1073\/pnas.1012525107","volume":"107","author":"CJ Sneeringer","year":"2010","unstructured":"Sneeringer CJ, Scott MP, Kuntz KW, Knutson SK, Pollock RM, Richon VM et al. Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas. Proc Natl Acad Sci USA 2010; 107: 20980\u201320985.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu201286_CR55","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","volume":"117","author":"DB Yap","year":"2011","unstructured":"Yap DB, Chu J, Berg T, Schapira M, Cheng SW, Moradian A et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 2011; 117: 2451\u20132459.","journal-title":"Blood"},{"key":"BFleu201286_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011; 471: 189\u2013195.","journal-title":"Nature"},{"key":"BFleu201286_CR57","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1093\/nar\/gkq244","volume":"38","author":"D Pasini","year":"2010","unstructured":"Pasini D, Malatesta M, Jung HR, Walfridsson J, Willer A, Olsson L et al. Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 2010; 38: 4958\u20134969.","journal-title":"Nucleic Acids Res"},{"key":"BFleu201286_CR58","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","volume":"18","author":"L Rui","year":"2010","unstructured":"Rui L, Emre NC, Kruhlak MJ, Chung HJ, Steidl C, Slack G et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell 2010; 18: 590\u2013605.","journal-title":"Cancer Cell"},{"key":"BFleu201286_CR59","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1146\/annurev-immunol-020711-075027","volume":"30","author":"AL Shaffer","year":"2012","unstructured":"Shaffer AL, Young RM, Staudt LM . Pathogenesis of human B-cell lymphomas. Ann Rev Immunol 2012; 30: 565\u2013610.","journal-title":"Ann Rev Immunol"},{"key":"BFleu201286_CR60","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1182\/asheducation-2009.1.353","volume":"2009","author":"AA Ferrando","year":"2009","unstructured":"Ferrando AA . The role of NOTCH1 signaling in T-ALL. Hematol Am Soc Hematol Educ Program 2009; 2009: 353\u2013361.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"BFleu201286_CR61","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.2009.07816.x","volume":"146","author":"M Di Ianni","year":"2009","unstructured":"Di Ianni M, Baldoni S, Rosati E, Ciurnelli R, Cavalli L, Martelli MF et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br J Haematol 2009; 146: 689\u2013691.","journal-title":"Br J Haematol"},{"key":"BFleu201286_CR62","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","volume":"119","author":"R Kridel","year":"2012","unstructured":"Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 2012; 119: 1963\u20131971.","journal-title":"Blood"},{"key":"BFleu201286_CR63","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1084\/jem.20111855","volume":"208","author":"C Lobry","year":"2011","unstructured":"Lobry C, Oh P, Aifantis I . Oncogenic and tumor suppressor functions of Notch in cancer: it's NOTCH what you think. J Exp Med 2011; 208: 1931\u20131935.","journal-title":"J Exp Med"},{"key":"BFleu201286_CR64","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.20080277","volume":"205","author":"BJ Thompson","year":"2008","unstructured":"Thompson BJ, Jankovic V, Gao J, Buonamici S, Vest A, Lee JM et al. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med 2008; 205: 1395\u20131408.","journal-title":"J Exp Med"},{"key":"BFleu201286_CR65","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012; 119: 521\u2013529.","journal-title":"Blood"},{"key":"BFleu201286_CR66","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2141.2010.08368.x","volume":"151","author":"P Sportoletti","year":"2010","unstructured":"Sportoletti P, Baldoni S, Cavalli L, Del Papa B, Bonifacio E, Ciurnelli R et al. NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. Br J Haematol 2010; 151: 404\u2013406.","journal-title":"Br J Haematol"},{"key":"BFleu201286_CR67","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","volume":"119","author":"V Balatti","year":"2012","unstructured":"Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 2012; 119: 329\u2013331.","journal-title":"Blood"},{"key":"BFleu201286_CR68","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3324\/haematol.2011.060129","volume":"97","author":"I Del Giudice","year":"2011","unstructured":"Del Giudice I, Rossi D, Chiaretti S, Marinelli M, Tavolaro S, Gabrielli S et al. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL. Haematologica 2011; 97: 437\u2013441.","journal-title":"Haematologica"},{"key":"BFleu201286_CR69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature09671","volume":"470","author":"VN Ngo","year":"2011","unstructured":"Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, Lim KH et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 470: 115\u2013119.","journal-title":"Nature"},{"key":"BFleu201286_CR70","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ni.2094","volume":"12","author":"L Rui","year":"2011","unstructured":"Rui L, Schmitz R, Ceribelli M, Staudt LM . Malignant pirates of the immune system. Nat Immunol 2011; 12: 933\u2013940.","journal-title":"Nat Immunol"},{"issue":"5","key":"BFleu201286_CR71","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/leu.2011.320","volume":"26","author":"T L Lasho","year":"2011","unstructured":"Lasho TL, Finke CM, Hanson CA, Jimma T, Knudson RA, Ketterling RP et al. SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients. Leukemia 2011; e-pub ahead of print 8 November 2011; doi:10.1038\/leu.2011.320.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201286","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:17:48Z","timestamp":1648739868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,9]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["BFleu201286"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.86","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,9]]},"assertion":[{"value":"6 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}